Search

Author/Creator Weber, Denis

1. Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2018)

Authors:
Di Leo, Angelo; Johnston, Stephen; Lee, Keun Seok; Ciruelos, Eva; Lønning, Per E; Janni, Wolfgang; O'Regan, Ruth; Mouret-Reynier, Marie-Ange; Kalev, Dimitar; Egle, Daniel; Csőszi, Tibor; Bordonaro, Roberto; Decker, Thomas; Tjan-Heijnen, Vivianne C G; Blau, Sibel; Schirone, Alessio; Weber, Denis; ...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 1(2018)
Page Start:
87
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Time‐Variable Exposure Experiments in Conjunction with Higher Tier Population and Effect Modeling to Assess the Risk of Chlorotoluron to Green Algae. (25th September 2019)

Authors:
Weber, Denis; Weyman, Gabriel; Fruhmann, Thomas; Gagniarre, Marion; Minten, Barbara; Memmert, Ulrich
Journal:
Environmental toxicology and chemistry
Issue:
Volume 38:Number 11(2019)
Page Start:
2520
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search